img

Global Infectious Bursal Disease Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Infectious Bursal Disease Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Infectious Bursal Disease Vaccine is used to prevent infectious bursal disease in chickens, which is one of the main infectious diseases in the chicken industry.
Infectious Bursal Disease Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Infectious Bursal Disease Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Veterinary Pharmacy and Online Sale are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Infectious Bursal Disease Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Infectious Bursal Disease Vaccine key manufacturers include Zoetis, Merck, Elanco, Boehringer Ingelheim, Ceva, Qingdao Yibang Biological Engineering Co., Ltd., Shandong Lvdu Biological Technology Co., Ltd., Plyco Bioengineering Co., Ltd. and Ruipu Biopharmaceutical Co., Ltd., etc. Zoetis, Merck, Elanco are top 3 players and held % sales share in total in 2022.
Infectious Bursal Disease Vaccine can be divided into Live and Inactivated, etc. Live is the mainstream product in the market, accounting for % sales share globally in 2022.
Infectious Bursal Disease Vaccine is widely used in various fields, such as Veterinary Pharmacy, Online Sale and Others,, etc. Veterinary Pharmacy provides greatest supports to the Infectious Bursal Disease Vaccine industry development. In 2022, global % sales of Infectious Bursal Disease Vaccine went into Veterinary Pharmacy filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Infectious Bursal Disease Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Zoetis
Merck
Elanco
Boehringer Ingelheim
Ceva
Qingdao Yibang Biological Engineering Co., Ltd.
Shandong Lvdu Biological Technology Co., Ltd.
Plyco Bioengineering Co., Ltd.
Ruipu Biopharmaceutical Co., Ltd.
Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
Segment by Type
Live
Inactivated

Segment by Application


Veterinary Pharmacy
Online Sale
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Infectious Bursal Disease Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Infectious Bursal Disease Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Infectious Bursal Disease Vaccine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Infectious Bursal Disease Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Infectious Bursal Disease Vaccine introduction, etc. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Infectious Bursal Disease Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Infectious Bursal Disease Vaccine Market Overview
1.1 Infectious Bursal Disease Vaccine Product Overview
1.2 Infectious Bursal Disease Vaccine Market Segment by Type
1.2.1 Live
1.2.2 Inactivated
1.3 Global Infectious Bursal Disease Vaccine Market Size by Type
1.3.1 Global Infectious Bursal Disease Vaccine Market Size Overview by Type (2024-2034)
1.3.2 Global Infectious Bursal Disease Vaccine Historic Market Size Review by Type (2024-2024)
1.3.3 Global Infectious Bursal Disease Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Infectious Bursal Disease Vaccine Sales Breakdown by Type (2024-2024)
1.4.2 Europe Infectious Bursal Disease Vaccine Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Infectious Bursal Disease Vaccine Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Infectious Bursal Disease Vaccine Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Infectious Bursal Disease Vaccine Sales Breakdown by Type (2024-2024)
2 Global Infectious Bursal Disease Vaccine Market Competition by Company
2.1 Global Top Players by Infectious Bursal Disease Vaccine Sales (2024-2024)
2.2 Global Top Players by Infectious Bursal Disease Vaccine Revenue (2024-2024)
2.3 Global Top Players by Infectious Bursal Disease Vaccine Price (2024-2024)
2.4 Global Top Manufacturers Infectious Bursal Disease Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Infectious Bursal Disease Vaccine Market Competitive Situation and Trends
2.5.1 Infectious Bursal Disease Vaccine Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Infectious Bursal Disease Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Infectious Bursal Disease Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Infectious Bursal Disease Vaccine Market
2.8 Key Manufacturers Infectious Bursal Disease Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Infectious Bursal Disease Vaccine Status and Outlook by Region
3.1 Global Infectious Bursal Disease Vaccine Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Infectious Bursal Disease Vaccine Historic Market Size by Region
3.2.1 Global Infectious Bursal Disease Vaccine Sales in Volume by Region (2024-2024)
3.2.2 Global Infectious Bursal Disease Vaccine Sales in Value by Region (2024-2024)
3.2.3 Global Infectious Bursal Disease Vaccine Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Infectious Bursal Disease Vaccine Forecasted Market Size by Region
3.3.1 Global Infectious Bursal Disease Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Infectious Bursal Disease Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Infectious Bursal Disease Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Infectious Bursal Disease Vaccine by Application
4.1 Infectious Bursal Disease Vaccine Market Segment by Application
4.1.1 Veterinary Pharmacy
4.1.2 Online Sale
4.1.3 Others
4.2 Global Infectious Bursal Disease Vaccine Market Size by Application
4.2.1 Global Infectious Bursal Disease Vaccine Market Size Overview by Application (2024-2034)
4.2.2 Global Infectious Bursal Disease Vaccine Historic Market Size Review by Application (2024-2024)
4.2.3 Global Infectious Bursal Disease Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Infectious Bursal Disease Vaccine Sales Breakdown by Application (2024-2024)
4.3.2 Europe Infectious Bursal Disease Vaccine Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Infectious Bursal Disease Vaccine Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Infectious Bursal Disease Vaccine Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Infectious Bursal Disease Vaccine Sales Breakdown by Application (2024-2024)
5 North America Infectious Bursal Disease Vaccine by Country
5.1 North America Infectious Bursal Disease Vaccine Historic Market Size by Country
5.1.1 North America Infectious Bursal Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Infectious Bursal Disease Vaccine Sales in Volume by Country (2024-2024)
5.1.3 North America Infectious Bursal Disease Vaccine Sales in Value by Country (2024-2024)
5.2 North America Infectious Bursal Disease Vaccine Forecasted Market Size by Country
5.2.1 North America Infectious Bursal Disease Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Infectious Bursal Disease Vaccine Sales in Value by Country (2024-2034)
6 Europe Infectious Bursal Disease Vaccine by Country
6.1 Europe Infectious Bursal Disease Vaccine Historic Market Size by Country
6.1.1 Europe Infectious Bursal Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Infectious Bursal Disease Vaccine Sales in Volume by Country (2024-2024)
6.1.3 Europe Infectious Bursal Disease Vaccine Sales in Value by Country (2024-2024)
6.2 Europe Infectious Bursal Disease Vaccine Forecasted Market Size by Country
6.2.1 Europe Infectious Bursal Disease Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Infectious Bursal Disease Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Infectious Bursal Disease Vaccine by Region
7.1 Asia-Pacific Infectious Bursal Disease Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Infectious Bursal Disease Vaccine Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Infectious Bursal Disease Vaccine Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Infectious Bursal Disease Vaccine Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Infectious Bursal Disease Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Infectious Bursal Disease Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Infectious Bursal Disease Vaccine Sales in Value by Region (2024-2034)
8 Latin America Infectious Bursal Disease Vaccine by Country
8.1 Latin America Infectious Bursal Disease Vaccine Historic Market Size by Country
8.1.1 Latin America Infectious Bursal Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Infectious Bursal Disease Vaccine Sales in Volume by Country (2024-2024)
8.1.3 Latin America Infectious Bursal Disease Vaccine Sales in Value by Country (2024-2024)
8.2 Latin America Infectious Bursal Disease Vaccine Forecasted Market Size by Country
8.2.1 Latin America Infectious Bursal Disease Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Infectious Bursal Disease Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Infectious Bursal Disease Vaccine by Country
9.1 Middle East and Africa Infectious Bursal Disease Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Infectious Bursal Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Infectious Bursal Disease Vaccine Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Infectious Bursal Disease Vaccine Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Infectious Bursal Disease Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Infectious Bursal Disease Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Infectious Bursal Disease Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Zoetis
10.1.1 Zoetis Company Information
10.1.2 Zoetis Introduction and Business Overview
10.1.3 Zoetis Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Zoetis Infectious Bursal Disease Vaccine Products Offered
10.1.5 Zoetis Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Merck Infectious Bursal Disease Vaccine Products Offered
10.2.5 Merck Recent Development
10.3 Elanco
10.3.1 Elanco Company Information
10.3.2 Elanco Introduction and Business Overview
10.3.3 Elanco Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Elanco Infectious Bursal Disease Vaccine Products Offered
10.3.5 Elanco Recent Development
10.4 Boehringer Ingelheim
10.4.1 Boehringer Ingelheim Company Information
10.4.2 Boehringer Ingelheim Introduction and Business Overview
10.4.3 Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Boehringer Ingelheim Infectious Bursal Disease Vaccine Products Offered
10.4.5 Boehringer Ingelheim Recent Development
10.5 Ceva
10.5.1 Ceva Company Information
10.5.2 Ceva Introduction and Business Overview
10.5.3 Ceva Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Ceva Infectious Bursal Disease Vaccine Products Offered
10.5.5 Ceva Recent Development
10.6 Qingdao Yibang Biological Engineering Co., Ltd.
10.6.1 Qingdao Yibang Biological Engineering Co., Ltd. Company Information
10.6.2 Qingdao Yibang Biological Engineering Co., Ltd. Introduction and Business Overview
10.6.3 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Products Offered
10.6.5 Qingdao Yibang Biological Engineering Co., Ltd. Recent Development
10.7 Shandong Lvdu Biological Technology Co., Ltd.
10.7.1 Shandong Lvdu Biological Technology Co., Ltd. Company Information
10.7.2 Shandong Lvdu Biological Technology Co., Ltd. Introduction and Business Overview
10.7.3 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Products Offered
10.7.5 Shandong Lvdu Biological Technology Co., Ltd. Recent Development
10.8 Plyco Bioengineering Co., Ltd.
10.8.1 Plyco Bioengineering Co., Ltd. Company Information
10.8.2 Plyco Bioengineering Co., Ltd. Introduction and Business Overview
10.8.3 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Products Offered
10.8.5 Plyco Bioengineering Co., Ltd. Recent Development
10.9 Ruipu Biopharmaceutical Co., Ltd.
10.9.1 Ruipu Biopharmaceutical Co., Ltd. Company Information
10.9.2 Ruipu Biopharmaceutical Co., Ltd. Introduction and Business Overview
10.9.3 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Products Offered
10.9.5 Ruipu Biopharmaceutical Co., Ltd. Recent Development
10.10 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
10.10.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information
10.10.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Introduction and Business Overview
10.10.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Products Offered
10.10.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Infectious Bursal Disease Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Infectious Bursal Disease Vaccine Industrial Chain Analysis
11.4 Infectious Bursal Disease Vaccine Market Dynamics
11.4.1 Infectious Bursal Disease Vaccine Industry Trends
11.4.2 Infectious Bursal Disease Vaccine Market Drivers
11.4.3 Infectious Bursal Disease Vaccine Market Challenges
11.4.4 Infectious Bursal Disease Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Infectious Bursal Disease Vaccine Distributors
12.3 Infectious Bursal Disease Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Live
Table 2. Major Company of Inactivated
Table 3. Global Infectious Bursal Disease Vaccine Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Infectious Bursal Disease Vaccine Sales by Type (2024-2024) & (K Units)
Table 5. Global Infectious Bursal Disease Vaccine Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Infectious Bursal Disease Vaccine Sales by Type (2024-2024) & (US& Million)
Table 7. Global Infectious Bursal Disease Vaccine Market Share in Value by Type (2024-2024)
Table 8. Global Infectious Bursal Disease Vaccine Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Infectious Bursal Disease Vaccine Sales by Type (2024-2034) & (K Units)
Table 10. Global Infectious Bursal Disease Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Infectious Bursal Disease Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Infectious Bursal Disease Vaccine Sales Market Share in Value by Type (2024-2034)
Table 13. Global Infectious Bursal Disease Vaccine Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Infectious Bursal Disease Vaccine Sales by Type (2024-2024) & (K Units)
Table 15. North America Infectious Bursal Disease Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Infectious Bursal Disease Vaccine Sales (K Units) by Type (2024-2024)
Table 17. Europe Infectious Bursal Disease Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Infectious Bursal Disease Vaccine Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Infectious Bursal Disease Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Infectious Bursal Disease Vaccine Sales (K Units) by Type (2024-2024)
Table 21. Latin America Infectious Bursal Disease Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Infectious Bursal Disease Vaccine Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Infectious Bursal Disease Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Infectious Bursal Disease Vaccine Sales by Company (2024-2024) & (K Units)
Table 25. Global Infectious Bursal Disease Vaccine Sales Share by Company (2024-2024)
Table 26. Global Infectious Bursal Disease Vaccine Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Infectious Bursal Disease Vaccine Revenue Share by Company (2024-2024)
Table 28. Global Market Infectious Bursal Disease Vaccine Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Infectious Bursal Disease Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Infectious Bursal Disease Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Infectious Bursal Disease Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Infectious Bursal Disease Vaccine Market
Table 33. Key Manufacturers Infectious Bursal Disease Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Infectious Bursal Disease Vaccine Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Infectious Bursal Disease Vaccine Sales by Region (2024-2024) & (K Units)
Table 37. Global Infectious Bursal Disease Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Infectious Bursal Disease Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Infectious Bursal Disease Vaccine Sales Market Share in Value by Region (2024-2024)
Table 40. Global Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Infectious Bursal Disease Vaccine Sales by Region (2024-2034) & (K Units)
Table 42. Global Infectious Bursal Disease Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Infectious Bursal Disease Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Infectious Bursal Disease Vaccine Sales Market Share in Value by Region (2024-2034)
Table 45. Global Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Infectious Bursal Disease Vaccine Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Infectious Bursal Disease Vaccine Sales by Application (2024-2024) & (K Units)
Table 48. Global Infectious Bursal Disease Vaccine Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Infectious Bursal Disease Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Infectious Bursal Disease Vaccine Sales Market Share in Value by Application (2024-2024)
Table 51. Global Infectious Bursal Disease Vaccine Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Infectious Bursal Disease Vaccine Sales by Application (2024-2034) & (K Units)
Table 53. Global Infectious Bursal Disease Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Infectious Bursal Disease Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Infectious Bursal Disease Vaccine Sales Market Share in Value by Application (2024-2034)
Table 56. Global Infectious Bursal Disease Vaccine Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Infectious Bursal Disease Vaccine Sales by Application (2024-2024) (K Units)
Table 58. North America Infectious Bursal Disease Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Infectious Bursal Disease Vaccine Sales by Application (2024-2024) (K Units)
Table 60. Europe Infectious Bursal Disease Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Infectious Bursal Disease Vaccine Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Infectious Bursal Disease Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Infectious Bursal Disease Vaccine Sales by Application (2024-2024) (K Units)
Table 64. Latin America Infectious Bursal Disease Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Infectious Bursal Disease Vaccine Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Infectious Bursal Disease Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Infectious Bursal Disease Vaccine Sales by Country (2024-2024) & (K Units)
Table 68. North America Infectious Bursal Disease Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Infectious Bursal Disease Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Infectious Bursal Disease Vaccine Sales Market Share in Value by Country (2024-2024)
Table 71. North America Infectious Bursal Disease Vaccine Sales by Country (2024-2034) & (K Units)
Table 72. North America Infectious Bursal Disease Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Infectious Bursal Disease Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Infectious Bursal Disease Vaccine Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Infectious Bursal Disease Vaccine Sales by Country (2024-2024) & (K Units)
Table 76. Europe Infectious Bursal Disease Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Infectious Bursal Disease Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Infectious Bursal Disease Vaccine Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Infectious Bursal Disease Vaccine Sales by Country (2024-2034) & (K Units)
Table 80. Europe Infectious Bursal Disease Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Infectious Bursal Disease Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Infectious Bursal Disease Vaccine Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Infectious Bursal Disease Vaccine Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Infectious Bursal Disease Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Infectious Bursal Disease Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Infectious Bursal Disease Vaccine Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Infectious Bursal Disease Vaccine Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Infectious Bursal Disease Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Infectious Bursal Disease Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Infectious Bursal Disease Vaccine Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Infectious Bursal Disease Vaccine Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Infectious Bursal Disease Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Infectious Bursal Disease Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Infectious Bursal Disease Vaccine Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Infectious Bursal Disease Vaccine Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Infectious Bursal Disease Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Infectious Bursal Disease Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Infectious Bursal Disease Vaccine Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Infectious Bursal Disease Vaccine Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Infectious Bursal Disease Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Infectious Bursal Disease Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Infectious Bursal Disease Vaccine Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Infectious Bursal Disease Vaccine Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Infectious Bursal Disease Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Infectious Bursal Disease Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Infectious Bursal Disease Vaccine Sales Market Share in Value by Country (2024-2034)
Table 107. Zoetis Company Information
Table 108. Zoetis Introduction and Business Overview
Table 109. Zoetis Infectious Bursal Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Zoetis Infectious Bursal Disease Vaccine Product
Table 111. Zoetis Recent Development
Table 112. Merck Company Information
Table 113. Merck Introduction and Business Overview
Table 114. Merck Infectious Bursal Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Merck Infectious Bursal Disease Vaccine Product
Table 116. Merck Recent Development
Table 117. Elanco Company Information
Table 118. Elanco Introduction and Business Overview
Table 119. Elanco Infectious Bursal Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Elanco Infectious Bursal Disease Vaccine Product
Table 121. Elanco Recent Development
Table 122. Boehringer Ingelheim Company Information
Table 123. Boehringer Ingelheim Introduction and Business Overview
Table 124. Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Boehringer Ingelheim Infectious Bursal Disease Vaccine Product
Table 126. Boehringer Ingelheim Recent Development
Table 127. Ceva Company Information
Table 128. Ceva Introduction and Business Overview
Table 129. Ceva Infectious Bursal Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Ceva Infectious Bursal Disease Vaccine Product
Table 131. Ceva Recent Development
Table 132. Qingdao Yibang Biological Engineering Co., Ltd. Company Information
Table 133. Qingdao Yibang Biological Engineering Co., Ltd. Introduction and Business Overview
Table 134. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product
Table 136. Qingdao Yibang Biological Engineering Co., Ltd. Recent Development
Table 137. Shandong Lvdu Biological Technology Co., Ltd. Company Information
Table 138. Shandong Lvdu Biological Technology Co., Ltd. Introduction and Business Overview
Table 139. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product
Table 141. Shandong Lvdu Biological Technology Co., Ltd. Recent Development
Table 142. Plyco Bioengineering Co., Ltd. Company Information
Table 143. Plyco Bioengineering Co., Ltd. Introduction and Business Overview
Table 144. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product
Table 146. Plyco Bioengineering Co., Ltd. Recent Development
Table 147. Ruipu Biopharmaceutical Co., Ltd. Company Information
Table 148. Ruipu Biopharmaceutical Co., Ltd. Introduction and Business Overview
Table 149. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product
Table 151. Ruipu Biopharmaceutical Co., Ltd. Recent Development
Table 152. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information
Table 153. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Introduction and Business Overview
Table 154. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product
Table 156. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Development
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Infectious Bursal Disease Vaccine Market Trends
Table 160. Infectious Bursal Disease Vaccine Market Drivers
Table 161. Infectious Bursal Disease Vaccine Market Challenges
Table 162. Infectious Bursal Disease Vaccine Market Restraints
Table 163. Infectious Bursal Disease Vaccine Distributors List
Table 164. Infectious Bursal Disease Vaccine Downstream Customers
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Infectious Bursal Disease Vaccine Product Picture
Figure 2. Global Infectious Bursal Disease Vaccine Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Infectious Bursal Disease Vaccine Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Infectious Bursal Disease Vaccine Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Live
Figure 6. Global Live Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Inactivated
Figure 8. Global Inactivated Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Infectious Bursal Disease Vaccine Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Infectious Bursal Disease Vaccine Sales Market Share by Type in 2022 & 2034
Figure 11. North America Infectious Bursal Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Infectious Bursal Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Infectious Bursal Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Infectious Bursal Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Infectious Bursal Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Infectious Bursal Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Infectious Bursal Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Infectious Bursal Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Infectious Bursal Disease Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Infectious Bursal Disease Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Infectious Bursal Disease Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Infectious Bursal Disease Vaccine Revenue in 2022
Figure 23. Infectious Bursal Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Veterinary Pharmacy
Figure 25. Global Veterinary Pharmacy Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Online Sale
Figure 27. Global Online Sale Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global Infectious Bursal Disease Vaccine Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Infectious Bursal Disease Vaccine Sales Market Share by Application in 2022 & 2034
Figure 32. North America Infectious Bursal Disease Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. North America Infectious Bursal Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Europe Infectious Bursal Disease Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Europe Infectious Bursal Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Infectious Bursal Disease Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Infectious Bursal Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Latin America Infectious Bursal Disease Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Infectious Bursal Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Infectious Bursal Disease Vaccine Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Infectious Bursal Disease Vaccine Manufacturing Cost Structure
Figure 43. Infectious Bursal Disease Vaccine Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries